Retraction: Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3 (PLoS ONE (2015) 10:5 (e0125634) DOI: 10.1371/journal.pone.0125634);Cell surface GRP78 accelerated breast cancer cell proliferation and migration by activating STAT3

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yao, Xiaoli ^a   Liu, Hua ^b,c   Zhang, Xinghua ^a   Zhang, Liang ^a   Li, Xiang ^a   Wang, Changhua ^c   Sun, Shengrong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b First People's Hospital of Lianyungang   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 78 ANTIBODY; JANUS KINASE; PROTEIN ANTIBODY; STAT3 PROTEIN; UNCLASSIFIED DRUG; HEAT SHOCK PROTEIN; MOLECULAR CHAPERONE GRP78; NEUTRALIZING ANTIBODY; STAT3 PROTEIN, HUMAN;

ADULT; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE OVEREXPRESSION; GRP78 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MCF 7 CELL LINE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SERODIAGNOSIS; VIRAL GENE DELIVERY SYSTEM; ADENOVIRIDAE; AGED; AGONISTS; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CANCER GRADING; CANCER STAGING; CELL MOTION; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOVIRIDAE;

ADENOVIRIDAE; ADULT; AGED; ANTIBODIES, NEUTRALIZING; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HEAT-SHOCK PROTEINS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84929359186     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0284594     Document Type: Erratum

References (48)

1. Banhegyi G, Baumeister P, Benedetti A, Dong D, Fu Y, Lee AS, et al. Endoplasmic reticulum stress. Annals of the New York Academy of Sciences. 2007; 1113:58-71. Epub 2007/05/08. doi: 10.1196/annals.1391.007 PMID: 17483206.
2. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS letters. 2007; 581(19):3641-51. Epub 2007/05/08. doi: 10.1016/j.febslet.2007.04.045 PMID: 17481612; PubMed Central PMCID: PMC2040386.
3. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Critical reviews in eukaryotic gene expression. 1994; 4(1):1-18. PMID: 7987045.
4. Haas IG. BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum. Experientia. 1994; 50(11-12):1012-20. PMID: 7988659.
5. Li Z. Glucose regulated protein 78: a critical link between tumor microenvironment and cancer hallmarks. Biochimica et biophysica acta. 2012; 1826(1):13-22. Epub 2012/03/20. doi: 10.1016/j.bbcan.2012.02.001 PMID: 22426159.
6. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer research. 2007; 67(8):3496-9. Epub 2007/04/19. doi: 10.1158/0008-5472.CAN-07-0325 PMID: 17440054.
7. Luo B, Lee AS. The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene. 2013; 32(7):805-18. Epub 2012/04/18. doi: 10.1038/onc.2012.130 PMID: 22508478; PubMed Central PMCID: PMC3819728.
8. Roller C, Maddalo D. The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment. Frontiers in pharmacology. 2013; 4:10. doi: 10.3389/fphar.2013.00010 PMID: 23403503; PubMed Central PMCID: PMC3568707.
9. Zhang Y, Tseng CC, Tsai YL, Fu X, Schiff R, Lee AS. Cancer cells resistant to therapy promote cell surface relocalization of GRP78 which complexes with PI3K and enhances PI(3,4,5)P3 production. PloS one. 2013; 8(11):e80071. Epub 2013/11/19. doi: 10.1371/journal.pone.0080071 PMID: 24244613; PubMed Central PMCID: PMCPmc3823711.
10. Liu R, Li X, Gao W, Zhou Y, Wey S, Mitra SK, et al. Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis. Clinical cancer research: an official journal of the American Association for Cancer Research. 2013; 19(24):6802-11. Epub 2013/09/21. doi: 10.1158/1078-0432.ccr-13-1106 PMID: 24048331.
11. Ni M, Zhang Y, Lee AS. Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting. The Biochemical journal. 2011; 434(2):181-8. Epub 2011/02/12. doi: 10.1042/BJ20101569 PMID: 21309747; PubMed Central PMCID: PMC3353658.
12. Zhang XX, Li HD, Zhao S, Zhao L, Song HJ, Wang G, et al. The cell surface GRP78 facilitates the invasion of hepatocellular carcinoma cells. BioMed research international. 2013; 2013:917296. Epub 2014/01/03. doi: 10.1155/2013/917296 PMID: 24383061; PubMed Central PMCID: PMCPmc3870640.
13. Li Z, Zhang L, Zhao Y, Li H, Xiao H, Fu R, et al. Cell-surface GRP78 facilitates colorectal cancer cell migration and invasion. The international journal of biochemistry & cell biology. 2013; 45(5):987-94. Epub 2013/03/15. doi: 10.1016/j.biocel.2013.02.002 PMID: 23485528.
14. Misra UK, Payne S, Pizzo SV. Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen. The Journal of biological chemistry. 2011; 286(2):1248-59. Epub 2010/11/09. doi: 10.1074/jbc.M110.129767 PMID: 21056970; PubMed Central PMCID: PMC3020732.
15. Misra UK, Pizzo SV. Ligation of cell surface GRP78 with antibody directed against the COOH-terminal domain of GRP78 suppresses Ras/MAPK and PI 3-kinase/AKT signaling while promoting caspase activation in human prostate cancer cells. Cancer biology & therapy. 2010; 9(2):142-52. Epub 2010/04/07. PMID: 20368692.
16. Misra UK, Mowery Y, Kaczowka S, Pizzo SV. Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis. Molecular cancer therapeutics. 2009; 8(5):1350-62. Epub 2009/05/07. doi: 10.1158/1535-7163.MCT-08-0990 PMID: 19417154.
17. Xiong A, Yang Z, Shen Y, Zhou J, Shen Q. Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention. Cancers. 2014; 6(2):926-57. Epub 2014/04/20. doi: 10.3390/cancers6020926 PMID: 24743778; PubMed Central PMCID: PMCPmc4074810.
18. Siveen KS, Sikka S, Surana R, Dai X, Zhang J, Kumar AP, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochimica et biophysica acta. 2014; 1845 (2):136-54. Epub 2014/01/07. doi: 10.1016/j.bbcan.2013.12.005 PMID: 24388873.
19. Clevenger CV. Roles and regulation of stat family transcription factors in human breast cancer. The American journal of pathology. 2004; 165(5):1449-60. Epub 2004/10/29. doi: 10.1016/s0002-9440(10)63403-7 PMID: 15509516; PubMed Central PMCID: PMCPmc1618660.
20. Zhu S, Yao F, Li WH, Wan JN, Zhang YM, Tang Z, et al. PKC?-dependent activation of the ubiquitin proteasome system is responsible for high glucose-induced human breast cancer MCF-7 cell proliferation, migration and invasion. Asian Pacific journal of cancer prevention: APJCP. 2013; 14(10):5687-92. Epub 2013/12/03. PMID: 24289563.
21. Satoh T, Furuta K, Tomokiyo K, Nakatsuka D, Tanikawa M, Nakanishi M, et al. Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor. Journal of neurochemistry. 2000; 75(3):1092-102. Epub 2000/08/11. PMID: 10936191.
22. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C, et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. The Journal of biological chemistry. 2000; 275(26):20127-35. Epub 2000/04/25. doi: 10.1074/jbc.M909580199 PMID: 10777512.
23. Robertson D, Savage K, Reis-Filho JS, Isacke CM. Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue. BMC cell biology. 2008; 9:13. Epub 2008/03/28. doi: 10.1186/1471-2121-9-13 PMID: 18366689; PubMed Central PMCID: PMCPmc2288605.
24. Yeung BH, Kwan BW, He QY, Lee AS, Liu J, Wong AS. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis. Oncogene. 2008; 27(53):6782-9. Epub 2008/09/09. doi: 10.1038/onc.2008.290 PMID: 18776923.
25. Davidson DJ, Haskell C, Majest S, Kherzai A, Egan DA, Walter KA, et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer research. 2005; 65(11):4663-72. Epub 2005/06/03. doi: 10.1158/0008-5472.CAN-04-3426 PMID: 15930284.
26. Philippova M, Ivanov D, Joshi MB, Kyriakakis E, Rupp K, Afonyushkin T, et al. Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival. Molecular and cellular biology. 2008; 28(12):4004-17. Epub 2008/04/16. doi: 10.1128/MCB.00157-08 PMID: 18411300; PubMed Central PMCID: PMC2423122.
27. Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, et al. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009; 28(24):2324-36. Epub 2009/05/08. doi: 10.1038/onc.2009.97 PMID: 19421146; PubMed Central PMCID: PMC2749668.
28. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 2009; 138(2):377-88. Epub 2009/07/28. doi: 10.1016/j.cell.2009.05.022 PMID: 19632185; PubMed Central PMCID: PMC2774252.
29. Messmer UK, Pereda-Fernandez C, Manderscheid M, Pfeilschifter J. Dexamethasone inhibits TNFalpha-induced apoptosis and IAP protein downregulation in MCF-7 cells. British journal of pharmacology. 2001; 133(4):467-76. doi: 10.1038/sj.bjp.0704093 PMID: 11399663; PubMed Central PMCID: PMC1572806.
30. Mukhopadhyay R, Theriault RL, Price JE. Increased levels of alpha6 integrins are associated with the metastatic phenotype of human breast cancer cells. Clinical & experimental metastasis. 1999; 17(4):325-32. PMID: 10545019.
31. Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer research. 2008; 68(15):6241-50. doi: 10.1158/0008-5472.CAN-07-6849 PMID: 18676848; PubMed Central PMCID: PMC2561279.
32. de Ridder GG, Ray R, Pizzo SV. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice. Melanoma research. 2012; 22(3):225-35. Epub 2012/04/13. doi: 10.1097/CMR.0b013e32835312fd PMID: 22495669.
33. Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer cell. 2014; 25(5):563-73. doi: 10.1016/j.ccr.2014.03.015 PMID: 24823636.
34. Scriven P, Coulson S, Haines R, Balasubramanian S, Cross S, Wyld L. Activation and clinical significance of the unfolded protein response in breast cancer. British journal of cancer. 2009; 101(10):1692-8. Epub 2009/10/29. doi: 10.1038/sj.bjc.6605365 PMID: 19861963; PubMed Central PMCID: PMC2778547.
35. Zhang Y, Liu R, Ni M, Gill P, Lee AS. Cell surface relocalization of the endoplasmic reticulum chaperone and unfolded protein response regulator GRP78/BiP. The Journal of biological chemistry. 2010; 285 (20):15065-75. doi: 10.1074/jbc.M109.087445 PMID: 20208072; PubMed Central PMCID: PMC2865300.
36. Delpino A, Castelli M. The 78 kDa glucose-regulated protein (GRP78/BIP) is expressed on the cell membrane, is released into cell culture medium and is also present in human peripheral circulation. Bioscience reports. 2002; 22(3-4):407-20. Epub 2003/01/09. PMID: 12516782.
37. Wang XH, Liu BR, Qu B, Xing H, Gao SL, Yin JM, et al. Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy. Neoplasma. 2011; 58(2):158-71. Epub 2011/02/01. PMID: 21275467.
38. Gonzalez-Gronow M, Selim MA, Papalas J, Pizzo SV. GRP78: a multifunctional receptor on the cell surface. Antioxidants & redox signaling. 2009; 11(9):2299-306. Epub 2009/04/01. doi: 10.1089/ARS.2009.2568 PMID: 19331544.
39. Misra UK, Pizzo SV. Activated alpha2-macroglobulin binding to cell surface GRP78 induces T-loop phosphorylation of Akt1 by PDK1 in association with Raptor. PloS one. 2014; 9(2):e88373. Epub 2014/02/12. doi: 10.1371/journal.pone.0088373 PMID: 24516643; PubMed Central PMCID: PMCPmc3916429.
40. Gray PC, Vale W. Cripto/GRP78 modulation of the TGF-beta pathway in development and oncogenesis. FEBS letters. 2012; 586(14):1836-45. Epub 2012/02/07. doi: 10.1016/j.febslet.2012.01.051 PMID: 22306319; PubMed Central PMCID: PMC3723343.
41. Shani G, Fischer WH, Justice NJ, Kelber JA, Vale W, Gray PC. GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth. Molecular and cellular biology. 2008; 28(2):666-77. Epub 2007/11/10. doi: 10.1128/MCB.01716-07 PMID: 17991893; PubMed Central PMCID: PMC2223411.
42. Misra UK, Pizzo SV. Receptor-recognized alpha(2)-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. PloS one. 2012; 7(12):e51735. Epub 2012/12/29. doi: 10.1371/journal.pone.0051735 PMID: 23272152; PubMed Central PMCID: PMCPmc3522726.
43. Guo GG, Patel K, Kumar V, Shah M, Fried VA, Etlinger JD, et al. Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research. 2002; 22(5):555-63. Epub 2002/06/13. doi: 10.1089/10799900252982034 PMID: 12060494.
44. Vogt PK, Hart JR. PI3K and STAT3: a new alliance. Cancer discovery. 2011; 1(6):481-6. Epub 2012/02/22. doi: 10.1158/2159-8290.cd-11-0218 PMID: 22348200; PubMed Central PMCID: PMCPmc3279943.
45. Hart JR, Liao L, Yates JR 3rd, Vogt PK. Essential role of Stat3 in PI3K-induced oncogenic transformation. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(32):13247-52. Epub 2011/07/27. doi: 10.1073/pnas.1110486108 PMID: 21788516; PubMed Central PMCID: PMCPmc3156164.
46. Shravah J, Wang B, Pavlovic M, Kumar U, Chen DD, Luo H, et al. Propofol mediates signal transducer and activator of transcription 3 activation and crosstalk with phosphoinositide 3-kinase/AKT. Jak-Stat. 2014; 3:e29554. Epub 2014/08/12. doi: 10.4161/jkst.29554 PMID: 25105067; PubMed Central PMCID: PMC4124059.
47. Siddiquee K, Zhang S, Guida WC, Blaskovich MA, Greedy B, Lawrence HR, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(18):7391-6. Epub 2007/04/28. doi: 10.1073/pnas.0609757104 PMID: 17463090; PubMed Central PMCID: PMC1863497.
48. Lin L, Amin R, Gallicano GI, Glasgow E, Jogunoori W, Jessup JM, et al. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling. Oncogene. 2009; 28(7):961-72. Epub 2009/01/13. doi: 10.1038/onc.2008.448 PMID: 19137011; PubMed Central PMCID: PMC2703464.